Therefore, the aim of this study was to analyze the EZH2 gene expression in pediatric patients with MDS, concerning their association with karyotypes, MDS subtypes and evolution from MDS to AML, giving new insights into pediatric MDS pathogenesis. This evidence concerns the gene EZH2 and myelodysplastic syndrome.